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Abstract
The host’s immune system plays a key role in modulating growth of pathogens and the intestinal microbiota in the gut. In
particular, inflammatory bowel disorders and pathogen infections induce shifts of the resident commensal microbiota which
can result in overgrowth of Enterobacteriaceae (‘‘inflammation-inflicted blooms’’). Here, we investigated competition of the
human pathogenic Salmonella enterica serovar Typhimurium strain SL1344 (S. Tm) and commensal E. coli in inflammation-
inflicted blooms. S. Tm produces colicin Ib (ColIb), which is a narrow-spectrum protein toxin active against related
Enterobacteriaceae. Production of ColIb conferred a competitive advantage to S. Tm over sensitive E. coli strains in the
inflamed gut. In contrast, an avirulent S. Tm mutant strain defective in triggering gut inflammation did not benefit from
ColIb. Expression of ColIb (cib) is regulated by iron limitation and the SOS response. CirA, the cognate outer membrane
receptor of ColIb on colicin-sensitive E. coli, is induced upon iron limitation. We demonstrate that growth in inflammation-
induced blooms favours expression of both S. Tm ColIb and the receptor CirA, thereby fuelling ColIb dependent
competition of S. Tm and commensal E. coli in the gut. In conclusion, this study uncovers a so-far unappreciated role of
inflammation-inflicted blooms as an environment favouring ColIb-dependent competition of pathogenic and commensal
representatives of the Enterobacteriaceae family.
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Introduction
Enteric Salmonella enterica serovar Typhimurium (S. Tm)
infection is antagonized by a highly complex intestinal microbiota,
a condition termed colonization resistance. Disruption of coloni-
zation resistance by oral antibiotic therapy, germfree state or an
immature microbiota of low complexity results in increased
susceptibility to oral infection with pathogens of the Enterobacteri-
aceae family [1,2,3]. In addition to the named conditions,
inflammatory changes in the intestine induce dysbiosis and favour
Enterobacteriaceae overgrowth [4,5,6]. Recently, we have shown that
S. Tm-induced gut inflammation mediates parallel blooms of S.
Tm and host-intrinsic commensal E. coli [7,8]. In these blooms,
both bacteria can reach high densities (.108 cfu/ml) while the
residual microbiota is outgrown [7]. Therefore, under inflamma-
tory conditions, commensal E. coli are one of the main competitors
of S. Tm. In the inflamed gut, environmental conditions
encountered by bacteria vastly differ from the situation in the
absence of inflammation. By resisting antimicrobial defences,
utilizing iron acquisition systems and exploiting anaerobic electron
acceptors (e.g. NO3
2, tetrathionate), Enterobacteriaceae can capital-
ize on inflammatory conditions [9,10,11,12,13,14].
Besides exploitative competition for resources, bacteria can
directly antagonize one another by producing antimicrobials, such
as bacteriocins. Bacteriocins produced by Enterobacteriaceae (E. coli,
Salmonella and relatives) are termed colicins. They have a narrow
spectrum of activity and act only against phylogenetically close
relatives. Colicins kill by one of three general mechanisms: pore
formation in the inner membrane, nuclease activity or interference
with cell wall synthesis [15]. We have shown that growth of S. Tm
in inflammation-induced blooms promotes horizontal transfer of
the conjugative pCol1B9-plasmid (in the following termed P2) to
commensal E. coli strains [7]. P2 encodes the locus for colicin Ib
(ColIb) production (cib) and immunity (imm). In blooms, ColIb was
shown to increase the fitness of S. Tm in competition with
commensal, colicin-sensitive E. coli. However, it has remained
unclear if ColIb only affords a benefit for S. Tm in inflammation-
inflicted blooms or also in the absence of gut inflammation.
ColIb belongs to the group of pore-forming colicins [16]. ColIb
is closely related to ColIa and most of its structural/functional
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properties can be inferred from ColIa [17]. Free ColIa/b binds to
the outer-membrane receptor CirA, a catecholate siderophore
receptor, and traverses the outer membrane in a TonB-dependent
way [18,19,20]. The exact mode of outer-membrane translocation
is still unclear but a recent study suggests that two molecules of
CirA are required, one for ColIa/ColIb binding, the second one
for its translocation [18,21]. ColIa/ColIb forms a pore in the inner
membrane of sensitive bacteria which leads to disruption of the
electrochemical membrane gradient and consequent bacterial
death [22]. ColIa/ColIb producers protect themselves by expres-
sion of the immunity protein (imm) which interferes with ColIa/
ColIb action in the inner membrane [23]. In addition, resistance
to ColIb can be gained by alterations of the cell-surface receptor
CirA or mutations in the TonB-dependent import pathway [24].
ColIa/ColIb expression is regulated in a Fur- and LexA-
dependent way [25]. The Fur protein binds FeII and thereby
measures the intracellular FeII pool [26]. In the iron-bound state,
Fur acts as a transcriptional repressor of iron-regulated promoters
which is released under iron-limiting conditions. In addition, the
ColIb gene cib is also repressed by the LexA protein, the regulator
of the SOS response. The SOS response is launched when
bacteria sense DNA damage (e.g. DNA double strands breaks)
[27]. As a consequence, the RecA protease is activated and cleaves
the LexA repressor protein which in turn activates an array of
genes involved in DNA repair, survival, prophages and also
colicins [15,28]. Interestingly, ColIa and ColIb are the only
reported colicins which are controlled by both, Fur and LexA.
This suggests that maximal expression of ColIa/b requires iron
limitation and stress conditions. Interestingly, the majority of other
colicins are only regulated by LexA and usually contain two LexA-
binding sites in their promoter to ensure tight repression.
Theoretical and experimental studies suggested that colicin
producers have a competitive advantage over non-producers when
colonizing the same ecological niche [29]. When directly tested in
competition experiments with sensitive strains in animal models,
colicin production only conferred a competitive advantage after
weeks [30,31]. In some cases, colicin-production even conferred
no detectable benefit despite colicin-dependent killing could be
demonstrated under in vitro conditions [32,33,34]. The underlying
reasons were attributed to colicin inactivation by proteases [33] or
reduced colicin activity under anaerobic conditions [35,36].
In the S. Tm mouse colitis model ColIb conferred an overt
fitness benefit for S. Tm in competition against a colicin-sensitive
E. coli strain [7]. This was somewhat surprising, considering the
lack of an apparent competitive advantage of colicin producers in
the reports mentioned above. Although different experimental
setups were used in previous studies, a key difference to our study
was the lack of concomitant gut inflammation. Therefore we
reasoned that the inflammatory response may somehow promote
ColIb dependent competition of S. Tm and E. coli. We tested this
idea and analyzed ColIb-dependent S. Tm and E. coli competition
under normal and inflammatory conditions in the mouse colitis
model. Our experiments revealed that the inflammatory response
creates conditions that potentiate the effects of colicins, both by
increasing their production and by mediating susceptibility of the
competitor. This finding has implications for colicin ecology and
points out the importance of colicins as fitness factor for bacterial
competition in Enterobacterial blooms in the inflamed gut.
Results
ColIb affords S. Tm a growth advantage over colicin-
sensitive E. coli strains in the inflamed, but not in the
normal gut
ColIb confers a fitness benefit to Salmonella Typhimurium (S.
Tm) over colicin-sensitive E. coli strains [7]. In vitro, the E. coli
Nissle (EcNissle) strain shows intermediate susceptibility to ColIb
(turbid inhibition zone), while the K-12 strain E. coli MG1655
(EcMG1655) is highly sensitive (clear inhibition zone; Figure S1A).
For this reason we selected EcMG1655 for our initial experiments.
First we tested, if the growth benefit of S. Tm over EcMG1655 is
ColIb-dependent. We performed the co-infection experiments
with S. Tm strains and EcMG1655 in the streptomycin Salmonella
mouse colitis model [2]. Here, we used gnotobiotic mice colonized
with a low-complexity microbiota (LCM) lacking any kind of
Enterobacteriaceae which may interfere with the experiment (i.e. by
the production of other colicins). Further, since the S. Tm P2-
plasmid is highly mobile and rapidly transferred to co-colonizing
E. coli strains in the gut [7], all S. Tm strains carried an additional
mutation in the origin of transfer of P2 (DoriT) to prevent
conjugation (Table 1). LCM mice pre-treated with streptomycin
were co-infected with 1:1 mixtures of EcMG1655 and either ColIb-
producing (S. TmDoriT) or ColIb-deficient strains (S. TmDoriT Dcib).
EcMG1655 was efficiently outcompeted by S. TmDoriT but not by the
ColIb-deficient mutant (Figure 1A,B). Both S. Tm strains induced
similar degrees of gut inflammation by day 4 p.i. (Figure 1CD).
This confirms that the competitive advantage of S. Tm over
EcMG1655 in the inflamed intestine is for the most part ColIb-
dependent. Next, we tested if an avirulent strain (S. TmDoriT avir)
defective in triggering an inflammatory response due to the
absence of functional type three secretion systems [37] would also
benefit from ColIb. Interestingly, in the absence of gut inflamma-
tion, S. TmDoriT avir did not out-compete EcMG1655 (Figure 1).
Previous studies on colicin-dependent bacterial competition
were using conventional mice. To this end we aimed to verify that
our key findings in gnotobiotic mice were also reproducible in a
more ‘‘natural’’ mouse model. To this end, we used the
streptomycin-treated mice with a conventional complex microbi-
ota. We used EcNissle for the co-infection experiments as in contrast
to LCM mice, EcMG1655 only poorly colonized conventional
Author Summary
Colicins are bacterial protein toxins which show potent
activity against sensitive strains in vitro. Ecological models
suggest that colicins play a major role in modulating
dynamics of bacterial populations in the gut. However,
previous studies could not readily confirm these predic-
tions by respective in vivo experiments. In animal models,
colicin-producing strains only show a minor or even absent
fitness benefit over sensitive competitors. Here, we
propose that the gut environment plays a crucial role in
generating conditions for bacterial competition by colicin
Ib (ColIb). Gut inflammation favours overgrowth of
Enterobacteriaceae (‘‘inflammation-inflicted Enterobacterial
blooms’’). We show that a pathogenic Salmonella Typhi-
murium (S. Tm) strain benefits from ColIb production in
competition against commensal E. coli upon growth in
inflammation-inflicted blooms. In the absence of gut
inflammation, ColIb production did not confer a compet-
itive advantage to S. Tm. In the inflamed gut, the genes for
ColIb production in S. Tm and its corresponding ColIb-
surface receptor CirA in E. coli were markedly induced, as
compared to the non-inflamed gut. Therefore, environ-
mental conditions in inflammation-inflicted blooms favour
colicin-dependent competition of Enterobacteriaceae by
triggering ColIb production and susceptibility at the same
time. Our findings reveal a role of colicins as important
bacterial fitness factors in inflammation-induced blooms.
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streptomycin-treated, S. TmDoriT infected mice (not shown). We set
up four different experimental groups of streptomycin-treated
mice (Figure 2). One group was co-infected with a virulent colicin-
producing, the other with a virulent colicin–deficient S. Tm strain
(S. TmDoriT or S. TmDoriT Dcib, respectively) and EcNissle. Both
groups developed strong Salmonella-induced gut inflammation
upon infection by day 4 p.i. (Figure 2E,F). The other two groups
were either co-infected with avirulent ColIb-producing S. Tm
(S. TmDoriT avir) and EcNissle, or avirulent ColIb-deficient S. Tm
(S. TmDP2 avir) and EcNissle. The latter two groups did not develop
gut inflammation within 4 days of infection (Figure 2E,F). In the
presence of inflammation, virulent ColIb-producing S. TmDoriT
grew up to similar numbers as EcNissle (to ,108 cfu/g) while
ColIb-deficient S. TmDoriT Dcib was outcompeted by EcNissle
(Figure 2B). This difference is also reflected in the competitive
index (Figure 2D). In the absence of inflammation, both co-
infecting strains (ColIb-producing S. TmDoriT avir and EcNissle) and
(ColIb-deficient S. TmDP2 avir and EcNissle) colonized well at day 1
post infection (Figure 2AC) but were out-competed (to ,107 cfu/
g) by the complex conventional microbiota, which recovers by day
5 after streptomycin-treatment (Figure 2B). No benefit of ColIb-
production was observed for the avirulent Salmonella strain. The
absolute ratio of Salmonella/EcNissle is different when compared to
Salmonella/EcMG1655 in LCM mice (Figure 1). We reason that this
is due to strain-specific differences between EcMG1655 and EcNissle
as well as due to differences between the gnotobiotic and complex
gut microbiota. This data verified that S. Tm/EcNissle competition
is only ColIb-dependent in the presence of gut inflammation.
In conclusion, these experiments prompted us to hypothesize
that, in the normal non-inflamed gut, either ColIb expression by S.
Tm was down-regulated or susceptibility of the Ec strains to ColIb
was decreased. To further address the mechanism of colicin-
dependent competition in the inflammation-induced blooms we
investigated the regulation of cib expression in S. Tm as well as the
susceptibility of Ec to ColIb in detail.
Regulation of S. Tm ColIb is induced by iron limitation
and the SOS response in vitro
The cib promoter region contains binding sites for the
transcriptional repressors Fur and LexA (Figure 3A; Figure S2).
We generated a cib promoter firefly-luciferase (luc)-reporter construct
as well as an affinity-purified polyclonal rabbit-a-ColIb antiserum
to analyze the regulation of ColIb expression. ColIb expression
was strongly up-regulated upon induction of the SOS response by
Table 1. Bacteria and plasmids used in this study.
S.Tm strains Lab-internal strain number Genotype Reference
S. Tmwt SB300 S. Tm strain SL1344 [77]
S. TmDcib M990 p2 cib imm::aphT [7]
S. Tmwt amp SB300 S. Tm carrying plasmid pWKS30 [71] [7]
S. TmDoriT M1407 p2 DoriT nikA::cat This study
S. Tmavir p2cm M996 DinvG; sseD::aphT p2::cat [7]
S. TmDoriT Dcib MAD1 p2 DoriT nikA::cat cib imm::aphT [7]
S. TmDP2 avir MBK15 DinvG; sseD::aphT cured of pColIB plasmid (P2) This study
S. Tmavir M557 DinvG; sseD::aphT [37]
S. TmDoriT avir LPN5 DinvG; sseD::aphT [37]; p2DoriT nikA::cat This study
E. coli strains
Ec DH5a Invitrogen
Ec BL21 DE3 Stratagene
EcNissle [7]
Ec8178 [7]
EcMG1655 E. coli K-12 wild type strain MG1655, streptomycin-resistant [78]
EcMG1655 DcirA LPN2 cirA::aphT This study
Plasmids
pWKS29 and pWKS30 [71]
pM979 Constitutive gfpmut2-reporter plasmid (ribosomal rpsM promoter) [69]
pLB02 Firefly-luciferase reporter plasmid [70]
pC831-2 expression of the ColIb (cib) immunity protein gene imm [7]
pLPN13 cirA-6-x-his This study
pLPN14 cib-6-x-his This study
pcirA-luc pLPN15 cirA-promoter firefly-luciferase reporter This study
pcib-luc pLPN16 cib-promoter firefly-luciferase reporter This study
pM1437 cib-promoter gfp-reporter This study
pLPN1 cirA-promoter gfp-reporter This study
pcompl. cirA pWRG693-1 cirA complementation vector This study
pcompl. cib pWRG694 cib complementation vector This study
doi:10.1371/journal.ppat.1003844.t001
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the antibiotic mitomycin C (0.25 mg/ml) as confirmed by luc-
reporter assays and immunoblot (Figure 3B–D). Depletion of Fe(III)
from culture media by chelation with 100 mM diethylenetriami-
nepentaacetic acid (DTPA) [38] had a comparable inductive effect
on ColIb production. Supplementation of both, mitomycin C and
DTPA lead to maximal induction of ColIb production and
secretion. This result confirmed that ColIb is de-repressed in
response to SOS signals and iron starvation.
Upregulation of EcMG1655 cirA under iron limitation
correlates with increased ColIb susceptibility
The outer membrane protein CirA is the receptor ColIa and
ColIb [18,19,20]. Expression of cirA is under negative control of
Fur [39] (Figure S3). To confirm FeIII-dependent regulation of the
cirA expression in EcMG1655, we generated a cirA promoter-luc-
reporter as well as a polyclonal rabbit-a-CirA antiserum. CirA
expression was strongly upregulated in LB media upon addition of
100 mM DTPA but not by mitomycin C as confirmed by luciferase
assay and immunoblot (Figure 4A, B). This confirmed that
EcMG1655 cirA was de-repressed in response to FeIII-starvation.
Next, we tested if cirA-expression correlated with sensitivity to
ColIb-mediated killing. As expected, EcMG1655 DcirA was resistant
to ColIb (Figure 5A). This phenotype was complemented by
expressing cirA on a plasmid in EcMG1655 DcirA (Figure S1C). We
further investigated, whether successive iron depletion would
increase ColIb sensitivity of EcMG1655. To this end, we performed
ColIb killing assays of EcMG1655 in M9 minimal media with
different concentrations of FeCl3 using the same amounts of
purified recombinant ColIb. Indeed, EcMG1655 was most sensitive
to ColIb in M9 without FeCl3 addition and became less susceptible
upon FeCl3 supplementation (Figure 5A). This correlated with
increased cirA expression under this condition, as determined by
immunoblot (Figure 5B). Thus, sensitivity of EcMG1655 to ColIb
increases with elevated cirA expression.
Figure 1. Colicin-dependent competition of S. Tm and E. coli in the gut in inflammation-induced ‘‘blooms’’ in gnotobiotic LCM mice.
Streptomycin-treated LCM-mice were co-infected with 1:1 mixtures of S. TmDoriT and EcMG1655, S. TmoriT Dcib and EcMG1655 or S. TmDoriT avir and EcMG1655.
(A) S. Tm (black) and E. coli (white) colonization densities were determined at day 4 p.i. in the cecum content (cfu/g). (B) Competitive indices (CI; ratio
of S. Tm/E. coli) were determined for individual mice shown in (A). Bars show the median. (C) Histopathological analysis of cecal tissue of the infected
mice shown in (A). Cecal tissue sections of the mice were stained with hematoxylin/eosin (H&E) and the degree of submucosal edema, neutrophil
infiltration, epithelial damage and loss of goblet cells was scored (Materials and Methods). 1–3: no pathological changes; 4–7: moderate inflammation;
above 8: severe inflammation. shown mean and StD. (D) Representative H&E–stained cecal sections of mice shown in (A–C). Magnification 100-fold.
Enlarged sections (squares) are shown in the lower panels. Dotted line: detection limit (1 cfu/g).
doi:10.1371/journal.ppat.1003844.g001
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Figure 2. Colicin-dependent competition of S. Tm and E. coli in the gut in inflammation-induced ‘‘blooms’’ in conventional mice.
Streptomycin-treated conventional mice were co-infected with 1:1 mixtures of S. TmDoriT Dcib and EcNissle, S. TmDoriT and EcNissle, S. TmDP2 avir and
EcNissle or S. TmDoriT avir and EcNissle. S. Tm (black) and E. coli (white) colonization densities (Cfu/g) were determined at day 1 (A) and day 4 p.i. (B) in the
feces and cecum content respectively. (C, D) Competitive indices (CI; ratio of S. Tm/E. coli) were determined for individual mice shown in (A) and (B).
Bars show the median. (E) Histopathological analysis of cecal tissue of the infected mice. Cecal tissue sections of the mice were stained with
Blooms Induce Colicin-Dependent Competition
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ColIb-dependent competition of S. Tm and EcMG1655 in
vitro is boosted by iron starvation and SOS-stress
To underscore the importance of environmental conditions for
ColIb-dependent competition of S. TmDoriT and EcMG1655, we per-
formed in vitro co-culture experiments. We followed growth of S.
TmDoriT and EcMG1655 and the respective mutants (S. TmDoriT Dcib
and EcMG1655 DcirA) in co-cultures under different conditions
(Figure 6). In the absence of supplements, S. TmDoriT and
EcMG1655 grew at similar rate. S. TmDoriT outcompeted EcMG1655
by ,7-fold after 8 h (mean titer S. TmDoriT: 1.76109 cfu/ml and
EcMG1655: 2.36108 cfu/ml; Figure 6A). In contrast, EcMG1655 was
outcompeted by several orders of magnitude after 8 h when
hematoxylin/eosin (H&E) and the degree of submucosal edema, neutrophil infiltration, epithelial damage and loss of goblet cells was scored
(Materials and Methods). 1–3: no pathological changes; 4–7: moderate inflammation; above 8: severe inflammation. Bars show mean and StD. (F)
Representative H&E–stained cecal sections of mice shown in (A–E). Magnification 100-fold. Enlarged sections (squares) are shown in the lower panels.
Dotted line: detection limit (1 cfu/g).
doi:10.1371/journal.ppat.1003844.g002
Figure 3. Expression of S. Tm ColIb is induced by iron limitation and the SOS response. (A) Organization of the ColIb locus showing
location of the Fur and LexA repressor binding sites in the ColIb (cib) promoter and the immunity protein gene (imm). Overnight cultures of S. TmDoriT
(B) and S. TmDoriT avir (C) carrying the reporter plasmid pcib-luc were re-inoculated 1:20 in fresh LB with indicated supplements (0.25 mg/ml mitomycin
C; 100 mM DTPA) and grown under aeration for 4 h. Cultures were normalized to OD600, bacteria were harvested and luciferase-activity was
measured in bacterial lysates. Relative luminescence units (RLU) per unit OD600 are indicated. (D) Overnight cultures of indicated S. Tm strains were
re-inoculated 1:20 in fresh LB with indicated supplements (0.25 mg/ml mitomycin C; 100 mM DTPA) and grown under aeration for 4 h. OD600 of the
cultures was normalized, bacteria were harvested and ColIb was detected in bacterial lysates as well as in the culture supernatant by immunoblot
using an affinity-purified rabbit-a-ColIb antiserum. S. Tm DnaK was detected as loading control.
doi:10.1371/journal.ppat.1003844.g003
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either DTPA (76107-fold), mitomycin C (16104-fold) or both
supplements (66106-fold) were added to the co-culture
(Figure 6D,G,J). S. Tm overgrowth in vitro was indeed ColIb-
dependent, as no killing was observed in the absence of ColIb
(S. TmDoriT Dcib) or CirA (EcMG1655 DcirA) (Figure 5B,C,E–L). Of
note, addition of 100 mM DTPA led to more pronounced killing of
EcMG1655 than mitomycin C with comparable amounts of ColIb
(Figure 3D), suggesting that iron depletion has a greater impact on
ColIb-dependent competition (i.e. by enhancing EcMG1655 cirA
expression and thereby its susceptibility to ColIb). The mutant
phenotypes of the S. Tm cib mutant as well as the EcMG1655 cirA
mutant were complemented using a plasmid-based complemen-
tation approach (Figure S1, Figure S4 and Figure S5).
Inflammation-induced Enterobacterial blooms foster cib
and cirA expression in vivo
The in vitro co-culture experiments of S. Tm and EcMG1655
showed that under iron excess conditions and in the absence of
triggers of the SOS response, ColIb confers little to no detectable
benefit to S. Tm. In contrast, under FeIII-limitation or in the
presence of stressors, S. Tm outcompetes E. coli, which is
dependent on ColIb production by S. Tm and cirA expression by
E. coli. Based on these data, we reasoned that ColIb-dependent
competition of S. Tm and EcMG1655 in the inflamed gut could
indeed be due to increased production of ColIb by S. Tm, or up-
regulation of the colicin receptor CirA by E. coli or both. To
address this, we analyzed expression of EcMG1655 cirA and S. Tm
ColIb (cib) in the streptomycin mouse colitis model using firefly-
luciferase reporter-constructs. To generate inflammatory and non-
inflammatory conditions in the intestine, LCM mice were infected
either with virulent (S. TmDoriT or S. Tmwt; +inflammation) or
avirulent (S. TmDoriT avir or S. Tmavir; -inflammation) Salmonella
strains, respectively. To investigate regulation of EcMG1655 cirA
expression, mice were co-infected with EcMG1655 carrying the pcirA-
luc-reporter plasmid (Figure 7A,C). To investigate regulation of S.
Tm cib expression, mice were co-infected with S. TmDoriT avir
carrying the pcib-luc-reporter plasmid (Figure 7B,D). The experi-
ments showed that luciferase levels for both the pcirA-luc- and the
pcib-luc-reporters were significantly increased in the inflamed
intestine (Figure 7A–D). Therefore, these data are in agreement
with our initial hypothesis and suggest that in response to gut
inflammation, ColIb production by S. Tm and susceptibility of
EcMG1655 to ColIb are increased. This explains how inflammation
fuels ColIb dependent competition of S. Tm and commensal E. coli
(Figure 8).
Discussion
Enterobacterial blooms provide environmental cues for
colicin production and susceptibility
Inflammatory conditions in the gut shape gut microbial
community structure and are characterized by an increased
prevalence of facultative anaerobic bacteria (‘‘blooms’’), in
particular members of the Enterobacteriaceae family [4,8,40].
Figure 4. E. coli cirA expression is upregulated in response to iron limitation. (A) An overnight culture of EcMG1655 carrying the reporter
plasmid pcirA-luc was re-inoculated 1:20 in fresh LB with indicated supplements (0.25 mg/ml mitomycin C; 100 mM DTPA) and grown under aeration
for 4 h. OD600 of the cultures was normalized, bacteria were harvested and luciferase-activity was measured in bacterial lysates. Relative luminescence
units (RLU) per unit OD600 are indicated. (B) Overnight cultures of Ec
MG1655 as well as EcMG1655 DcirA were re-inoculated 1:20 in fresh LB with indicated
supplements (0.25 mg/ml mitomycin C; 100 mM DTPA) and grown under aeration for 4 h. Cultures were normalized to OD600, bacteria were
harvested and CirA was detected in bacterial lysates by immunoblot using a rabbit-a-CirA antiserum. E. coli cytoplasmic protein DnaK was detected as
loading control.
doi:10.1371/journal.ppat.1003844.g004
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Commensal E. coli strains can hitchhike gut inflammation induced
by inflammatory bowel diseases or enteric pathogens (S. Tm or
Citrobacter rodentium) [5,7,12]. Commensal and pathogenic repre-
sentatives of the Enterobacteriaceae efficiently dwell in blooms as they
can exploit resources with increased abundance in the inflamed
gut (ethanolamine, the anaerobic electron-acceptors tetrathionate
and nitrate) [11,12,41]. Up to 15 different E. coli strains can be
detected in one individual human gut ecosystem [42]. Thus,
successful competition for resources should be of major impor-
tance for bacteria in order to come out on top and eventually
benefit from an episode of gut inflammation [8]. Here, we propose
that colicins such as ColIb are effective means to fight off
competing bacteria, particularly in inflammation-induced entero-
bacterial blooms.
Which environmental cues promote ColIb-dependent bacterial
competition in blooms? As an immediate inflammatory defence
reaction, the host deprives potential invading pathogens of
nutritionally-required iron. Neutrophils release iron-sequestering
lactoferrin upon degranulation [43]. Further, lipocalin 2 (LCN2),
an antimicrobial protein binding the bacterial siderophore
enterochelin [44] is abundantly expressed by neutrophils and
intestinal epithelial cells. LCN2 is produced in response to
infection with wildtype but not avirulent S. Tm strains in the
streptomycin-colitis model [9]. S. Tm overcomes LCN2-imposed
inhibition by production of salmochelin [45,46], a siderophore
resistant to binding by LCN2. Salmochelin is produced in a
Fur-dependent manner in response to iron limitation and
upregulated by S. Tm thriving in the inflamed gut [10]. Therefore,
host-mediated iron restriction in the inflamed gut poses an
environmental cue for inducing ColIb production by S. Tm. Other
cues for ColIb production are compounds triggering the SOS
response. Yet, the exact source and identity of those compounds in
the inflamed gut is ill-defined. The SOS response in Enterobacte-
riaceae can be triggered by antibiotics which directly affect DNA
integrity (mitomycin C), DNA replication via the DNA gyrase
(quinolones) or induce membrane stress (b-lactams) [28,47].
Further, oxidative stress induced by reactive oxygen species
(ROS), superoxides, H2O2 or free radicals formed by UV-light
induce DNA damage and thereby the SOS response [28,48].
Neutrophils infiltrating the intestinal lumen in response to
Salmonella infection as well as activated iNOS-producing epithelial
cells likely represent a source of free radicals and potential inducer
of the SOS response [40,49]. Recently, it was demonstrated that
E. coli indeed upregulates stress-induced proteins such as GroL,
RecA, YggE and the Fe-S cluster repair protein NfuA in the
inflamed gut [50].
Not only was the expression of cib increased in the inflamed gut,
but also the corresponding surface receptor cirA. CirA is the
receptor for monomers, dimers and linear trimers of 2,3-
dihydroxybenzoylserine, breakdown products of enterochelin
[51]. Further, it was shown, that cirA mutants are attenuated in
the uptake of monomeric catechol and its analogues [52]. In order
Figure 5. Induction of cirA expression increases sensitivity to ColIb of E. coli. (A) EcMG1655 and EcMG1655 DcirA were cultivated in M9 medium
o.n., mixed with soft agar and indicated concentrations of FeCl3 and overlaid on M9 agar plates. Paper discs with recombinant ColIb were placed on
the agar plate and the diameter of the inhibition zone (halo) was measured after 24 h. The detection limit (dotted line) is the size of the paper-disc
(6 mm). (B) cirA expression of E. coli grown in vitro in M9 medium supplemented with different concentrations of FeCl3. Overnight cultures of
EcMG1655 and EcMG1655 DcirA grown in M9 medium for 12 h were used for inoculation of 2 ml M9 medium supplemented with 1 mM, 10 mM, 0.1 mM or
1 mM FeCl3 and subcultured for 7 h. From each subculture, 250 ml (for an OD600 of 1) was taken, spun down at 4uC, 10 min, 10, 000 rpm. CirA was
detected by immunoblot in bacterial lysates using affinity-purified rabbit-a-CirA-antiserum. E. coli DnaK was detected as loading control.
doi:10.1371/journal.ppat.1003844.g005
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to avoid iron overload and its negative consequences (e.g. the
formation of hydroxyl-radicals), iron-uptake systems are tightly
controlled at the transcriptional level and only de-repressed under
iron-limiting conditions. In vitro, susceptibility to ColIb of E. coli
was drastically increased under FeIII-depleted conditions, which
correlated with elevated CirA protein levels. In the same way, the
in vitro competition experiments suggest that S. Tm benefits most
from ColIb production under iron-limiting conditions (76107-
fold). The growth advantage was lower in the presence of
mitomycin C (16104-fold) or under both iron limitation and
mitomycin C (66106-fold). Of note, the amount of free S. Tm
ColIb in the medium was even higher in the presence of
mitomycin C, than with addition of DTPA only (Figure 3D),
supporting the idea, that the expression level of cirA has a higher
impact on the competition, compared to that of ColIb
(Figure 6D,G). Hitherto, the underlying mechanism of ColIb-
release or secretion triggered by the SOS response is not known. In
conclusion, we reason that increased cirA expression and
consequential high susceptibility of E. coli to ColIb may explain
for the most part colicin-dependent competition in blooms
(Figure 8).
Interestingly, several other colicins parasitize siderophore outer
membrane receptors, which are all under control of the Fur-
regulon. ColM binds to the ferrichrome receptor FhuA while ColB
and ColD bind to FepA, the receptor for enterobactin [15]. This
suggests that increased sensitivity to colicin-mediated killing under
iron depletion may also apply for other colicins binding to TonB-
dependent outer-membrane transporters. Previously, it was shown
Figure 6. ColIb dependent competition of S. Tm and E. coli in vitro. Overnight cultures of S. TmDoriT and EcMG1655 (A, D, G, J), S. TmDoriT Dcib
and EcMG1655 (B, E, H, K) or S. TmDoriT and EcMG1655 DcirA (C, F, I, L) were diluted and normalized to an OD600 of 0.05 for each strain in fresh LB with
indicated supplements (0.25 mg/ml mitomycin C (Mito. C); 100 mM DTPA). Cfu/ml of both strains were determined at 0 h, 4 h, and 8 h after the start
of the subculture. Red lines: S. Tm strains, blue lines: E. coli strains. Dotted line: detection limit (2000 cfu/ml).
doi:10.1371/journal.ppat.1003844.g006
Blooms Induce Colicin-Dependent Competition
PLOS Pathogens | www.plospathogens.org 9 January 2014 | Volume 10 | Issue 1 | e1003844
Figure 7. S. Tm ColIb and the E. coli ColIb receptor CirA are induced in the inflamed gut. To measure in vivo regulation of E. coli cirA
expression, streptomycin-treated LCM-mice were co-infected with 1:1 mixtures of the luciferase-reporter strain EcMG1655 pcirA-luc and S. TmDoriT avir
(avirulent) or S. TmDoriT (wildtype), respectively (A, C). To measure in vivo regulation of S. Tm cib expression, streptomycin-treated LCM-mice were co-
infected with the luciferase-reporter strain S. TmDoriT pcib-luc and S. Tmavir (avirulent) or with S. Tmwt (wildtype), respectively (B, D). Bacteria were
harvested from cecal content and luciferase-activity was measured in cecum content (A, B). Relative luminescence units (RLU) per 108 cfu of the
reporter strain are indicated (C, D). Gut inflammation as determined by pathological score of cecal tissue sections of the infected mice. 1–3: no
pathological changes; 4–7: moderate inflammation; above 8: severe inflammation. Bars show the median. Arrow in (A) and (C) point at one animal
with atypically mild inflammatory symptoms.
doi:10.1371/journal.ppat.1003844.g007
Figure 8. Model for the role of colicins for bacterial competition in inflammation-induced blooms. (A) Under homeostatic conditions,
Enterobacteriaceae (blue, green) are reduced in numbers as they are kept in check by the obligate anaerobic microbiota (violet-blue). Under this
condition, colicin expression as well as expression of the colicin surface receptors are relatively repressed (high iron, no triggers of the SOS response).
(B) Upon induction of an inflammatory response, gut microbial ecology is altered leading to Enterobacterial blooms. Neutrophils transmigrate into
the gut lumen and produce iron-depleting agents (lipocalin, lactoferrin) and reactive oxygen and nitrogen species (ROS, RNS). This triggers SOS-and
Fur-dependent transcriptional responses in Enterobacteriaceae and colicin- and colicin-receptor expression is induced. Thereby, the inflammatory
response drives colicin-dependent enterobacterial competition.
doi:10.1371/journal.ppat.1003844.g008
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that killing of susceptible bacteria by pyocin, a bacteriocin
produced by Pseudomomas spp., is increased under iron-limited
conditions [53]. Pyocin binds the ferri-pyoverdine receptor FpvA,
which is controlled by Fur. In summary, physiological changes of
the murine intestine upon Salmonella-induced colitis are likely to
provide the environmental cues required for upregulation of both,
ColIb and its receptor CirA. Yet, we cannot rule out that other
physiological parameters altered in the inflamed gut also con-
tribute to the observed phenotype. So far, it is unclear if expression
of other types of colicins as well as other Enterobacteriaceae-derived
bacteriocins (microcins, pyocins, klebicins) would be upregulated
in the inflamed gut. The majority of these bacteriocins is only
under control of the SOS response and repressed by LexA and not
regulated in a Fur-dependent fashion. Thus, it remains to be
shown if the principle of colicin-colicin-receptor upregulation in
the inflamed gut also applies to other bacteriocins and their
respective receptors.
Colicin-dependent bacterial competition is enhanced in
the inflamed gut
Supposedly, colicins play a major role in mediating bacterial
population dynamics [54]. Superior fitness of colicinogenic over
sensitive strains in vivo could so far only be demonstrated in few
studies performing long-term competitive infection experiments
($12 weeks) [30,31]. In contrast, a number of other studies
reported that high bacteriocidal activity against closely related,
sensitive strains observed in vitro could not be recapitulated in in
vivo experiments (see below). Our data presented in this paper
might explain this puzzling observation: we suggest that the fitness
benefit of colicin production strongly depends on the environ-
mental conditions prevailing in the gut. Under normal conditions,
colicin expression and expression of their cognate receptors may
not be stimulated enough to induce colicin-dependent inhibition of
the sensitive strain. In the absence of gut inflammation, S. Tm did
not benefit from ColIb in competition with E. coli. Likewise,
competition experiments in germfree mice with a colicin-
producing E. coli and a sensitive strain resulted in equal
colonization levels of both strains over weeks (no inflammation
induced) [32,33,34] and similar results were obtained for other
strains and colicins [55,56]. The underlying reasons for the
absence of an overt fitness-benefit of colicin production were
attributed to colicin inactivation by intestinal proteases [33],
acquisition of colicin-resistances [55] or absent colicin activity
under anaerobic conditions [35,36]. Our study suggests that
absence of inflammatory conditions might be an additional
explanation.
Implications for the evolution of colicin-dependent
competition
Colicin production is a common trait in E. coli populations [54].
On average, 30% of natural E. coli populations produce one or
more colicins [57]. Many experimental and theoretical studies
have addressed the ecological consequences of colicin production
in bacterial populations [58,59]. In general, it is assumed, that
colicins afford a competitive advantage to the strain producing it.
However, the producer pays a fitness cost due to the higher
metabolic load of colicin synthesis as well as lethality of production
(e.g. lysis-mediated colicin release). Bacteria have partially
overcome this limitation by applying the principle of ‘division of
labor’. In a population of colicin producers, only a small fraction of
bacteria are induced to produce the colicin ( = phenotypic
heterogeneity) [60,61]. In recA negative strains decreased frequen-
cies of colicin producers were observed, suggesting that the rate of
colicin production is regulated by the SOS response [60]. This
strategy seems to be evolutionary successful, as colicins released by
the subpopulation serve as a ‘‘common good’’ for the whole
population and secure propagation of the shared genotype.
Nevertheless, colicin expression needs to be tightly controlled to
ensure, that the fraction of producers is kept at low rates under
conditions, when colicin is not required. Those conditions include
the lack of stress, nutrient starvation but also the absence of any
direct competitors.
Thus, we assume that colicin production of a bacterial
population should be confined to environmental niches which
are characterized by high density and diversity of competing E. coli
and close relatives. E. coli titers in the mammalian gut lumen are
rather low as the intestinal tract is dominated by strictly anaerobic
bacteria [62]. E. coli predominantly colonizes the mucus layer of
the large intestine where it thrives on mucin-derived sugars [63].
Thus, the intestinal mucus layer is one highly competitive
environment for E. coli and colicins may be beneficial for
competing for the preferred limiting substrates [64]. In contrast,
we identify inflammation-induced blooms as an alternative niche
for colicin-dependent Enterobacterial competition (Figure 8). Entero-
bacterial blooms can contain multiple closely-related species at high
concentrations which likely compete for the same resources.
Under this highly competitive situation, the chances are increased
that colicin-sensitive competitors are present at high numbers.
Thus, the bacteria may benefit hugely from colicin production
under this environmental condition. Moreover, the population size
of the colicin-producer is large enough to tolerate loss of a fraction
of the population due to suicidal colicin production. In summary,
the results presented here provide evidence that intestinal
inflammation drives colicin-dependent competition by bacteria
of the Enterobacteriaceae family. These findings shed new light on the
role of colicins as important fitness factors providing a competitive
advantage for growth in Enterobacterial blooms.
Materials and Methods
Ethics statement
All animal experiments were approved by the Regierung von
Oberbayern and the Kantonales Veterinäramt Zürich performed
according to national German and Swiss guidelines (Deutsches
TschG; Schweizer Kantonale TschV). The permit no. 55.2-1-54-
2532-49-11 (Germany) and 201/2007 (Switzerland).
Animal experiments
All mice used in the study were on C57BL/6J background and
bred at the Rodent Center, ETH Zürich and the Max-von-
Pettenkofer Institute, LMU Munich under SPF conditions in
individually ventilated cages. Low-complexity microbiota (LCM)
mice were generated by associating germfree mice with members
of the Altered Schaedler flora [65] as described previously [66].
Conventional SPF C57BL/6J mice were purchased from Janvier,
Le Genest Saint Isle. For infections, conventional and LCM mice
were pretreated with streptomycin and infected by gavage with
56107 cfu S. Tm or mixtures of S. Tm and E. coli as described [7].
For in vivo luciferase-assays, LCM mice were pretreated with
ampicillin (20 mg/animal 24 h prior to infection). Live bacterial
loads in the cecal content were determined by plating on
MacConkey-agar (Roth) with respective supplements (streptomy-
cin 100 mg/ml; kanamycin 30 mg/ml; chloramphenicol 30 mg/ml;
ampicillin 100 mg/ml and tetracycline 12,5 mg/ml). Histology of
the cecum was done at necropsy. Cecum tissue was embedded in
O.C.T. (Sakura, Torrance) and flash frozen. Cryosections (5 mm)
of the cecal tissue were H&E-stained and scored as described in
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detail in [6]. The parameters submucosal edema, PMN infiltra-
tion, loss of goblet cells and epithelial damage were scored
according to the severity of inflammatory symptoms yielding a
total score of 0–13 points. For infections, E. coli and S. Tm strains
were grown as described [67]. Briefly, cultures in LB supplement-
ed with 0.3M NaCl were inoculated with 2–3 bacterial colonies
from plates. Bacteria were grown over night for 12 h and
subcultures (1:20) for an additional 4 h. Bacteria were mixed (as
indicated) washed in PBS and applied to the mice in a total volume
of 50 ml by gavage.
Construction of bacterial mutants and plasmids
Bacterial strains and plasmids used in this study are listed in
Table 1. EcMG1655 DcirA (LPN2) was constructed using the lambda
Red recombinase system as described using pKD4 as template for
the kanamycin-resistance gene including the FRT-sites [68].
Briefly, EcMG1655 was transformed with the plasmid pKD46.
The kanamycin resistance cassette from plasmid pKD4 was
amplified by PCR using primers K12DcirA_Fwd/K12DcirA_Re
(Table S1). Correct recombination was verified by PCR using
primers cirA-up/cirA-down and cirA-up/cirA-d1 (Table S1). S.
Tmavir DoriT (LPN5) was generated by P22-transduction of the
DoriTnikA::cat allele from M1407 into M557 [37]. Correct
insertion was verified by PCR using primers DoriTnikArev_val,
DoriTnikA_val. The P2 plasmid was cured from S. Tm DinvG;
sseD::aphT cured as described previously [7]. For the generation of
c-terminal CirA-His-tag fusion, the open reading frame of cirA was
amplified from E coli Nissle genomic DNA by PCR, using
Fow_cirA_NheI and Re_cirA_XhoI primers (Table S1) and cloned
into pET-24c (Novagen) via NheI and XhoI to yield pLPN13. For
the generation of c-terminal ColIb-His-tag fusion, the ColIb gene
cib was amplified from S. Tmwt genomic DNA by PCR, using
primers Fow_colicin_NheI and Re_colicin_XhoI (Table S1) and
cloned into pET-24c via NheI and XhoI to yield pLPN14. To
generate pLPN1, the cirA promoter was amplified from E. coli Nissle
using pcirA-BamHI, pcirA-XbaI (Table S1) and inserted in BamHI
and XbaI digested pM979 [69]. For generation of pM1437, the cib
promoter from E. coli8178 was amplified using pColIb-XbaI,
pColIb-BamHI (Table S1) and inserted in pM968 [69] via
restriction with XbaI and BamHI. To generate pLPN15 and
pLPN16, the firefly-luciferase gene luc from pLB02 [70] was
amplified with Luc-for-BamHI and Luc-rev-HindIII primers
(Table S1) and inserted into BamHI/HindIII digested pLPN1 or
pM1437, respectively.
Primers pWSK29-Gbs-for and pWSK29-Gbs-rev were used in
a PCR with pWSK29 [71] as a template to amplify the low-copy-
number plasmid (Table S1). Primers CirA-pWSK29-Gbs-for and
CirA-pWSK29-Gbs-rev were used in a PCR with chromosomal
DNA of EcMG1655 as a template to amplify cirA including its
natural promoter. Primers Cib-Imm-pWSK29-Gbs-for and Cib-
Imm-pWSK29-Gbs-rev were used in a PCR with S. Typhimurium
strain SL1344 plasmid pCol1B9_SL1344 as a template to amplify
the cib/imm locus including both natural promoters. The pWSK29
PCR fragment was combined with the cirA or cib/imm fragment in
a Gibson assembly reaction [72]. Four microliters of the Gibson
assembly mix were transformed into chemically competent E. coli
Mach1 T1 cells (Life Technologies). Constructs were verified using
colony PCR, restriction analysis and sequencing.
Identification of regulator binding sites
For annotation of transcription factor binding sites (Fur and
LexA regulon), all known transcription factor binding sites of each
family one were taken from RegulonDB (version 8.0) [73] and a
binding motif was created using MEME [74]. The nucleotide
sequences of the cib (S. Tm SL1344; EMBL accession
no. FQ312003) and cirA promoter regions (E. coli MG1655
genome accession no. NC_000913.2) were searched for the
computed MEME binding site motifs using MAST [74].
Generation and affinity purification of recombinant
proteins
For expression of ColIb-His, we used E. coli BL21 transformed
with pC831-2 (expression of the ColIb immunity protein gene imm
[7]) and pLPN14. For expression of cirA-His we used E. coli BL21
transformed with pLPN13 (Table S1). Over-night cultures of
bacteria, grown at 37uC, 180 rpm in Luria-Bertani (LB) medium
containing antibiotics were used for inoculation of subcultures
(dilution 1:20). At OD600 between 0.6–0.8 the subcultures was
induced with 0.1 mM isopropyl b –D-thiogalactopyranoside
(IPTG) and incubated for additional 4 h at 37uC, 180 rpm.
Bacteria were harvested (4,500 rpm, 30 min at 4uC), resuspended
in 40 ml 16PBS and spun down at 5,000 rpm, 20 min at 4uC.
The pellet was frozen at 220uC. Thereafter, the pellet was thawed
and resuspended in 25 ml loading buffer (40 mM Na2HPO4,
0.3M NaCl, 5 mM Imidazol, pH 7.8), supplemented with 2 mM
phenylmethylsulfonyl fluoride (PMSF) and benzonase nuclease
(Novagen). Bacteria were lysed in the French Press (1,000 PSI) and
the lysate was filtered (0.22 mm). Further, the lysate was loaded on
a 5 ml HisTrap column (GE Healthcare), and purified using the
ÄKTA system (GE Healthcare). ColIb-His was eluted with 5 mM
Imidazole. The fractions containing the protein were desalted on a
5 ml HiTrap desalting column (GE Healthcare), using the ÄKTA
system and exchange buffer (20 mM Na2HPO4, 100 mM NaCl,
pH 7.4). CirA-His was purified as outlined above for ColIb-His,
but with following exceptions: loading buffer for the French Press
(8M Urea, 40 mM Na2HPO4, 0.3M NaCl, 5 mM Imidazol,
pH 7.8, 2 mM PMSF, and Benzonase nuclease): loading buffer for
HisTrap column (6M Urea, 40 mM Na2HPO4, 0.3M NaCl,
5 mM Imidazol, pH 7.8); exchange buffer (4M Urea, 20 mM
Na2HPO4, 100 mM NaCl, pH 7.4). Rabbit antisera against
ColIb-His and CirA-His were raised using standard protocols
(Pineda Antikörper-Service, Berlin, Germany). 6 mg/ml ColIb-
His (in 20 mM Na2HPO4, 100 mM NaCl, pH 7.4) and 6 mg/ml
CirA-His (in 20 mM Na2HPO4, 100 mM NaCl, 4M Urea,
pH 7.4) were used for immunization. Control and immune serum
were received from bleedings day 61, 90 and 135 post
immunization.
Affinity purification of rabbit-antisera
Affinity purification of polyclonal rabbit a-ColIb-His antiserum
was done using the Aminolink kit (Thermo Scientific) following the
manufacturer’s protocol with some minor modifications. For
ColIb-His, PBS was used as binding/wash buffer and 1M Glycine,
pH 2.7 was used as elution buffer. ColIb-His (stored in 20 mM
Na2HPO4, 100 mM NaCl, pH 7.4) was added to the binding
buffer at 1:3 ratio. Desalting of the affinity-purified rabbit-a-
ColIb-His antiserum was done using PD-10 desalting columns
with PBS as exchange buffer (GE Healthcare). For CirA-His, His-
tagged CirA (20 mM Na2HPO4, 100 mM NaCl, 4M Urea,
pH 7.4) was dialyzed against PBS using 5 ml Zebra Spin desalting
columns (Thermo scientific) shortly before coupling to the column.
Coupling was done with CirA-His (in PBS) and coupling buffer
supplemented with 4M Urea (MP Biomedicals). Desalting of the
affinity-purified rabbit-a-CirA-His was done with Zebra Spin
desalting columns with PBS containing 0.05% sodium azide
(Merk). Purified antisera were stored at 280uC with addition of
sodium azide to 0.01%.
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Colicin killing-assay
For measuring colicin production and -sensitivity, the colicin-
producing strain was grown o.n. as small spot (ø5 mm) on LB
agar containing 0.25 mg/ml mitomycin C (Roth). The plate
was overlaid with the tester strain in top-agar (0.75% agar).
Growth of the tester strain was analyzed after 24 h. Formation
of an inhibition zone (halo) around the producer indicated
production of colicin and sensitivity of the tester strain. For
determining ColIb sensitivity dependent on the FeIII concen-
tration, the assay was modified accordingly. Starter cultures of
E. coli in 3 ml M9 medium (40 mM Na2HPO462H2O, 20 mM
KH2PO4, 9 mM NaCl, 2 g/L NH4Cl, 1 mM MgSO4, 100 mM
CaCl2, 2 g/l D-glucose, 10 mg/l thiamine, 500 mg/l histidine)
were grown for 10 h and used for inoculation (1:20) of 2 ml
M9 medium, supplemented with 1 mM, 10 mM, 0.1 mM or
1 mM FeCl3 and grown for 12 h. From each subculture, 50 ml
was added to 5 ml 50uC 0.7% M9 top-agar (0.75% agar),
which was used to overlay M9 agar plates. Further, antimi-
crobial susceptibility test discs (Oxoid) were laid on each
plate and supplemented with 8 ml 1.3 mg/ml recombinant
His-tagged ColIb. The plates were incubated over-night at
37uC.
Growth of bacterial strains for in vitro assays
Bacteria were grown in a starter culture in LB or M9 media and
used for inoculation of subcultures (1:20), except of in vitro co-
cultures, where subcultures were inculcated to an OD600 of 0.05
for each strain. Following supplements were used: 0.25 mg/ml
mitomycin C (Roth); 100 mM diethylenetriaminepentaacetic acid
(DTPA; Sigma), 1 mM, 10 mM, 0.1 mM or 1 mM FeCl3 (Sigma).
All cultures were grown at 37uC on a wheel rotor, except of in vitro
co-cultures, where subcultures were grown in Erlenmeyer-flasks in
a shaker at 200 rpm.
Luciferase assay
Luciferase assays were performed as described [75]. Briefly,
overnight cultures (3 ml LB, 100 mg/ml ampicillin) were grown
for 12 h and used for 1:20 inoculation of 3 ml subcultures (LB,
100 mg/ml ampicillin with respective supplements) and grown for
4 h. From each subculture, 250 ml (of an OD600 of 1) was spun
down for 5 min, 14,000 rpm, 4uC. The supernatant was removed
and the bacterial pellet was frozen at 280uC for 1 h. Further, the
pellet was thawn and resuspended in 500 ml lysis buffer (100 mM
K2HPO4/KH2PO4 buffer, pH 7.8, 2 mM EDTA, 1% Triton X-
100, 5 mg/ml BSA, 1 mM DTT and 5 mg/ml lysozyme) and
incubated for 15 min at room temperature while vortexing every
3 minutes. Bacterial lysates (25 ml) were transferred in 96-well
plates (white; Thermo scientific) and 50 ml luciferase reagent
[1 mM (MgCO3)4Mg(OH)265H2O, 20 mM tricine, 0.1M
EDTA, 470 mM D(2) luciferin (Sigma), 530 mM Mg-ATP
(Sigma), 125 mM glycylglycine (Sigma), 270 mM Li3-coenzym A
(Sigma), 33 mM DTT] was added to each well. Luminescence
was measured using a FLUOstar Optima plate reader (BMG
Labtech).
For luciferase assay from bacteria extracted from cecum
content, the cecum content was harvested from infected mice
and shortly stored on ice. The cecum content was resuspended in
500 ml PBS (0.1% tergitol) and mixed in a tissue-lyser (Qiagen;
5 min; 50 Hz). Further, the cecum content was filtered through a
40 mm cell-sieve (Milian). Samples were taken to determine the
cfu/ml of the reporter strain by plating on MacConkey agar with
respective antibiotics. A defined volume (i.e. 900 ml) was pelleted at
4uC, 2 min, 14,000 rpm. The supernatant was removed and the
pellet was frozen in dry ice and stored at 280uC. The samples
were then thawn and processed as described above. Only values
above detection limit (control cecum content) were considered.
The relative luminescence units (rlu) per cfu luciferase-reporter
strain were calculated.
Generation of samples for immunoblot
Overnight cultures of 3 ml M9 medium, grown for 12 h were
used for inoculation (1:20) of 2 ml M9 medium supplemented with
1 mM, 10 mM, 0.1 mM or 1 mM FeCl3 subculture, grown for 7 h.
Starter culture of 3 ml LB, grown for 12 h was used for
inoculation of 3 ml LB with supplements grown for 4 h. From
each subculture, 250 ml (for an OD600 of 1) was taken, spun down
at 4uC, 10 min, 10, 000 rpm. The supernatant was removed and
bacterial pellet was frozen in liquid nitrogen and thawn at room
temperature for 15 min (repeated three times), resuspended in
100 ml lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM
EDTA, 0.25% nonidet P-40, 1 mg/ml lysozyme) and incubated in
thermomixer at 550 rpm at 23uC, for 1 h and thereafter spun
down at 4uC, 20 min, 14 000 rpm. Total protein was quantified in
the lysate using protein assay reagent (BioRad). Further, bacterial
lysate was added to protein loading buffer (50 mM Tris, 100 mM
DTT, 2% SDS, 0.1% bromphenolblue, 10% glycerol) and
incubated for 10 min at 95uC. For supernatant fractions 500 ml
(for an OD600 of 1) of the subculture were spun down twice,
supernatant was added to 56protein loading buffer and incubated
for 10 min at 95uC.
SDS-polyacrylamide gel electrophoresis (PAGE) and
immunoblot
Proteins were separated by SDS gel electrophoresis [76].
Proteins were transferred onto a nitrocellulose membrane (GE
Healthcare) at 300 mA for 2 h. The membrane was blocked in
PBS (0.1% tween; 5% milk powder) and probed with antisera
(affinity-purified a-CirA-His (1:50) or affinity-purified a-ColIb-
His (1:500). Goat-a-rabbit-HRP (GE-Healthcare) was used as
secondary antibody. For detection of E. coli and S. Tm DnaK, the
mouse monoclonal a-E. coli DnaK antibody (mAb 8E2/2; Enzo
Life Sciences) and a secondary goat-a-mouse-HRP (Sigma) was
used. Blots were developed with ECL detection system (GE
Healthcare).
Statistical analysis
Statistical analysis was performed using the exact Mann-
Whitney U Test (Graphpad Prism Version 5.01). P-values less
than 0.05 (2-tailed) were considered statistically significant.
Supporting Information
Figure S1 Halo-assay to confirm phenotypes of ColIb
production and susceptibility. (A) ColIb susceptibility of
EcNissle and EcMG1655. S. Tmwt was spotted on LB agar plates
containing mitomycin C and incubated o.n. to induce ColIb se-
cretion. EcNissle and EcMG1655 were cultivated in LB medium o.n.,
mixed with soft agar and overlaid on the agar plates. (B) Plasmid-
based complementation of the ColIb-deficient S. Tm mutant S.
TmDoriT Dcib. S. TmDoriT, S. TmDoriT Dcib and S. TmDoriT Dcib pcompl. cib
were spotted on LB agar plates containing mitomycin C and
incubated o.n. to induce ColIb secretion. EcMG1655 was cultivated
in LB medium o.n., mixed with soft agar and overlaid on the agar
plates. (C) Plasmid-based complementation of the CirA-deficient
EcMG1655 DcirA mutant. S. TmDoriT, and S. TmDoriT Dcib were spotted
on LB agar plates containing mitomycin C and incubated o.n.
to induce ColIb secretion. EcMG1655 DcirA and EcMG1655 DcirA
pcompl. cirA were cultivated in LB medium o.n., mixed with soft agar
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and overlaid on the agar plates. The experiments were done in
triplicates and the diameter of the ColIb inhibition zone (halo) was
measured after 24 hours. The detection limit (dotted line) is the
average size of the S. Tmwt colony.
(PDF)
Figure S2 Nucleotide sequence of S. Tmwt cib imm and
its respective promoter regions. Fur- and LexA repressor
binding sites were annotated to the cib and imm sequence region of
S. Tmwt as described in the materials and methods section. The
position of the Fur-box, LexA-box, major transcription start sites
and their corresponding 210 and 235 regions are indicated, as
well as the open reading frame and the prospective ribosome-
binding site (S.D.).
(PDF)
Figure S3 Nucleotide sequence of EcMG1655 cirA and its
promoter region. Fur-repressor binding site was annotated to
the cirA sequence region of EcMG1655 as described in the materials
and methods section. The position of the Fur-box, major
transcription start sites and their corresponding 210 and 235
regions are indicated, as well as the open reading frame and the
prospective ribosome-binding site (S.D.).
(PDF)
Figure S4 >Characterization of plasmid-based comple-
mentation of S. TmDoriT Dcib and EcMG1655 DcirA mutant
strains by western blot. Overnight cultures of indicated S. Tm
(A) and EcMG1655 strains (B) were re-inoculated 1:20 in fresh LB
with indicated supplements (0.25 mg/ml mitomycin C; 100 mM
DTPA) and grown under aeration for 4 h. Cultures were
normalized to OD600, bacteria were harvested and ColIb was
detected in bacterial lysates as well as in the culture supernatant by
immunoblot using an affinity-purified rabbit-a-ColIb antiserum
(A). S. Tm DnaK was detected as loading control (A). EcMG1655
CirA was detected in bacterial lysates by immunoblot using a
rabbit-a-CirA antiserum (B). E. coli cytoplasmic protein DnaK was
detected as loading control (B).
(PDF)
Figure S5 ColIb dependent competition of complement-
ed S. Tm and E. coli mutant strains in vitro. Overnight
cultures of S. TmDoriT and EcMG1655 DcirA pcompl. cirA (A, D, G, J), S.
TmDoriT Dcib and EcMG1655 DcirA pcompl. cirA (B, E, H, K) or S.
TmDoriT Dcib pcompl. cib and EcMG1655 (C, F, I, L) were diluted and
normalized to an OD600 of 0.05 for each strain in fresh LB with
indicated supplements (0.25 mg/ml mitomycin C (Mito. C);
100 mM DTPA). Cfu/ml of both strains were determined at
0 h, 4 h, and 8 h after start of the subculture. Red lines: S. Tm
strains, blue lines: E. coli strains. Dotted line: detection limit
(2000 cfu/ml). Plasmid-based reconstitution of cib and cirA to the
mutant strains leads to an over-complementation apparent by
ColIb-dependent killing of E. coli in LB in the absence of
supplements which is attributed to the multi-copy nature of the
complementation-plasmid (A, C).
(PDF)
Table S1 Primers used in this study. All PCR primer
sequences used in the study are listed.
(DOCX)
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